Person: Amarin

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

Biotech firm may not be sold until next year

AMARIN, the biotechnology firm developing a cholesterol drug, may not reach an agreement with a suitor until later this year or 2012, chief executive Joe Zakrzewski said.

Sat, 11 Jun, 2011

Amarin shares soar after drug trial

THE most advanced in-trial drug of Dublin-headquartered bio-pharmaceutical company, Amarin is being tipped for “blockbuster” status, following successful Phase-3 trials.

Tue, 19 Apr, 2011